|
ZNF207 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.456300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.349800E-02 |
| Normal-vs-Stage2 |
1.253200E-01 |
| Normal-vs-Stage3 |
2.863600E-01 |
| Normal-vs-Stage4 |
8.937500E-02 |
| Stage1-vs-Stage2 |
9.329800E-01 |
| Stage1-vs-Stage3 |
2.700600E-01 |
| Stage1-vs-Stage4 |
9.609200E-01 |
| Stage2-vs-Stage3 |
4.391000E-01 |
| Stage2-vs-Stage4 |
9.744800E-01 |
| Stage3-vs-Stage4 |
4.022400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.476500E-02 |
| Normal-vs-AfricanAmerican |
5.886600E-01 |
| Normal-vs-Asian |
1.151720E-02 |
| Caucasian-vs-AfricanAmerican |
1.222230E-02 |
| Caucasian-vs-Asian |
9.457900E-02 |
| AfricanAmerican-vs-Asian |
1.594320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.619030E-01 |
| Normal-vs-Female |
8.496400E-03 |
| Male-vs-Female |
6.433600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.207800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.800000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.034550E-01 |
| Normal-vs-Age(81-100Yrs) |
5.093400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.593000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.193200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.649600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.634000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.281200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.857000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.320500E-02 |
| Normal-vs-Grade 2 |
7.317800E-03 |
| Normal-vs-Grade 3 |
1.858200E-01 |
| Normal-vs-Grade 4 |
5.627800E-01 |
| Grade 1-vs-Grade 2 |
5.089400E-01 |
| Grade 1-vs-Grade 3 |
1.627200E-01 |
| Grade 1-vs-Grade 4 |
1.516210E-01 |
| Grade 2-vs-Grade 3 |
4.930500E-02 |
| Grade 2-vs-Grade 4 |
5.509600E-02 |
| Grade 3-vs-Grade 4 |
5.716000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.44130000000209E-05 |
| Normal-vs-ccB subtype |
2.204600E-01 |
| ccA subtype-vs-ccB subtype |
1.598730E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.621900E-02 |
| Normal-vs-N1 |
1.567800E-01 |
| N0-vs-N1 |
5.154800E-01 |
|
|
